Treatment Outcomes After Progression With Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma. Furubayashi N, Mochida M, Kijima A, Fujimoto Y, et al. Anticancer Res 2025;45:2185-2193.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Furubayashi N, Mochida M, Kijima A, Fujimoto Y, et al. Treatment Outcomes After Progression With Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma. Anticancer Res 2025;45:2185-2193.
PMID: 40295063